drugset / Trial / NCT00540098

Paroxetine vs Placebo Combined With Aerobic Exercise or Relaxation in Panic Disorder

NCT00540098

Phase 4 Completed 75 enrolled University of Göttingen GlaxoSmithKline · collab
RandomizedParallel-groupTriple-blindTreatment

Summary

Efficacy and safety of a 10-weeks treatment protocol of paroxetine vs. placebo in combination with regular aerobic exercise (running) or regular relaxation training in the treatment of panic disorder.

Timeline

Start
2001-09
Primary completion
Completion
2005-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Paroxetine Small molecule 40 mg

Indications